Search details
1.
Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy.
BMC Med
; 20(1): 369, 2022 10 25.
Article
in English
| MEDLINE | ID: mdl-36280874
2.
Ibrutinib combined with low-dose histone deacetylases inhibitor chidamide synergistically enhances the anti-tumor effect in B-cell lymphoma.
Hematol Oncol
; 40(5): 894-905, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35975476
3.
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphoma.
Hematol Oncol
; 40(4): 596-608, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35477179
Results
1 -
3
de 3
1
Next >
>>